

浏览全部资源
扫码关注微信
1.上海中医药大学 中药研究所,上海 201203
2.中国中医科学院 中药研究所,北京 100700
Received:30 August 2024,
Accepted:15 November 2024,
Published Online:22 November 2024,
Published:05 April 2025
移动端阅览
李源,杜寒倩,李佳珊等.基于均匀设计法优化菟丝子方对卵巢储备功能影响的组方配比及机制[J].中国实验方剂学杂志,2025,31(07):53-62.
LI Yuan,DU Hanqian,LI Jiashan,et al.Optimization and Mechanism Exploration of Tusizi Prescription for Ovarian Reserve Function Based on Uniform Design Method[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(07):53-62.
李源,杜寒倩,李佳珊等.基于均匀设计法优化菟丝子方对卵巢储备功能影响的组方配比及机制[J].中国实验方剂学杂志,2025,31(07):53-62. DOI: 10.13422/j.cnki.syfjx.20242039.
LI Yuan,DU Hanqian,LI Jiashan,et al.Optimization and Mechanism Exploration of Tusizi Prescription for Ovarian Reserve Function Based on Uniform Design Method[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(07):53-62. DOI: 10.13422/j.cnki.syfjx.20242039.
目的
2
通过均匀设计法结合体外实验,优化菟丝子方对卵巢储备功能影响的组方配比并探讨其作用机制。
方法
2
采用均匀设计法对菟丝子方水提物进行5因素11水平的实验设计,以细胞增殖与活性检测(CCK-8)实验测定菟丝子方水提物1~11处理的人卵巢颗粒细胞(KGN细胞)活力为指标,进行多元回归分析得出最优组方配比;在中药系统药理学数据库与分析平台(TCMSP)、中药百科全书数据库(ETCM)中查询活性成分潜在靶点,与疾病靶点取交集获得共同靶点,分别将共同靶点导入基因/蛋白质相互作用检索工具数据库(STRING)构建蛋白质-蛋白质相互作用(PPI)网络及基因功能注释数据库(DAVID)进行基因本体(GO)分析;以CCK-8实验测定金丝桃苷对卵巢生殖干细胞活力的影响;以CCK-8、细胞增殖检测试剂盒(EdU)、细胞凋亡检测试剂盒(TUNEL)、酶联免疫吸附测定法(ELISA)实验对均匀设计得出最优组方和菟丝子方水提物11(菟丝子-枸杞子-山药-茯苓-莲子4∶4∶2∶1∶1)在影响KGN细胞增殖、凋亡、雌二醇(E
2
)分泌方面进行对比研究,以期得出对卵巢储备功能影响的最优组方配比及初探其机制。
结果
2
菟丝子方的278个药物靶点和1 721个疾病靶点取交集,获得共同靶点147个;GO分析显示主要涉及细胞对外源性化合物刺激的反应、凋亡过程的负调控、正向调控细胞增殖等194个生物学过程,细胞膜、线粒体、神经元细胞体等84个细胞组成,酶结合、雌激素应答元件结合、核雌激素受体结合等144个分子功能;多元回归分析得出菟丝子方各药材按照菟丝子-枸杞子-山药-茯苓-莲子27∶30∶17∶12∶14组方时增强KGN细胞活力具有最佳效果;CCK-8结果表明,与正常组比较,金丝桃苷组卵巢生殖干细胞活力显著提高(
P
<
0.01);CCK-8和EdU结果表明,与正常组比较,均匀设计筛选出的最优组方和菟丝子方水提物11组KGN细胞增殖能力明显提高(
P
<
0.05,
P
<
0.01);TUNEL结果表明,与正常组比较,均匀设计筛选出的最优组方和菟丝子方水提物11组明显减少KGN细胞凋亡(
P
<
0.05);ELISA结果表明,与正常组比较,菟丝子方水提物11组显著促进KGN细胞E
2
的分泌(
P
<
0.05),而均匀设计得出的最优组方对KGN细胞E
2
的分泌差异无统计学意义。
结论
2
菟丝子方水提物11(菟丝子-枸杞子-山药-茯苓-莲子4∶4∶2∶1∶1)与均匀设计筛选出的组方(菟丝子-枸杞子-山药-茯苓-莲子27∶30∶17∶12∶14)均可能是菟丝子方改善卵巢储备功能的最佳组方配比,但尤以组方11配比效果最佳。菟丝子方可通过Hyperoside等活性成分,正向调控细胞增殖、抑制细胞凋亡等生物学过程和影响酶结合、雌激素应答元件结合等分子功能,从而促进KGN细胞增殖、E
2
分泌、抑制凋亡,进而发挥对卵巢储备功能的保护作用。
Objective
2
To optimize Tusizi prescription for ovarian reserve function based on the uniform design method combined with
in vitro
experiments and explore the underlying mechanisms of this prescription.
Methods
2
The uniform design method was adopted to design a 5-factor 11-level experiment on the water extract of Tusizi prescription. The cell-counting kit-8 (CCK-8) assay was employed to measure the
viability of human ovarian granulosa cells (KGN cells) treated with Tusizi prescription extracts 1-11, and multivariate regression analysis was performed to determine the optimal herb ratio in this prescription. The potential targets of active ingredients in the prescription were retrieved from traditional Chinese medicine systems pharmacology database and analysis platform (TCMSP) and encyclopedia of traditional Chinese medicine (ETCM). The common targets shared by Tusizi prescription and diminished ovarian reserve (DOR) were selected and imported into search tool for the retrieval of interacting genes/proteins (STRING) to construct a protein-protein interaction (PPI) network and into gene function annotation database (DAVID) for gene ontology (GO) analysis. The CCK-8 assay was used to measure the viability of ovarian germline stem cells treated with hyperoside. The CCK-8 assay, 5-ethynyl-2'-deoxyuridine (EdU) staining, terminal-deoxynucleoitidyl transferase mediated nick-end labeling (TUNEL), and enzyme-linked immunosorbent assay (ELISA) were employed to examine the proliferation, apoptosis, and estradiol (E
2
) secretion of KGN cells treated with the water extract 11 of Tusizi prescription (Cuscutae Semen-Lycii Fructus-Dioscoreae Rhizoma-Poria-Nelumbinis Semen 4∶4∶2∶1∶1) and the optimal prescription screened by uniform design. On this basis, the optimal prescription composition for maximizing the effect on ovarian reserve function was determined and preliminary insights into the underlying mechanisms of this prescription were gained.
Results
2
A total of 147 common targets were obtained from 278 targets of Tusizi prescription and 1 721 targets of DOR. GO analysis revealed 194 biological processes, primarily involving cellular responses to exogenous compound stimuli, negative regulation of apoptotic process, and positive regulation of cell proliferation. It identified 84 cellular components, including cell membrane, mitochondria, and neuronal cell body, as well as 144 molec
ular functions such as enzyme binding, estrogen response element binding, and nuclear estrogen receptor binding. The multivariate regression analysis revealed that when Tusizi prescription was composed of Cuscutae Semen, Lycii Fructus, Dioscoreae Rhizoma, Poria, and Nelumbinis Semen in a ratio of 27∶30∶17∶12∶14, the water extract of Tusizi prescription had the best effect of enhancing the viability of KGN cells. CCK-8 results showed that compared with the normal group, the hyperoside group demonstrated increased viability of ovarian germline stem cells (
P
<
0.01). The CCK-8, EdU, and ELISA results showed that compared with the normal group, the optimal prescription screened by uniform design and the water extract 11 of Tusizi prescription increased the proliferation and reduced the apoptosis of KGN cells (
P
<
0.05,
P
<
0.01). ELISA results showed that compared with the normal group, the water extract 11 of Tusizi prescription promoted the E
2
secretion of KGN cells (
P
<
0.05), while the optimal prescription screened by uniform design had no significant effect on the E
2
secretion.
Conclusion
2
Both the water extract 11 of Tusizi prescription (Cuscutae Semen-Lycii Fructus-Dioscoreae Rhizoma-Poria-Nelumbinis Semen 4∶4∶2∶1∶1) and the optimal prescription screened by uniform design (Cuscutae Semen-Lycii Fructus-Dioscoreae Rhizoma-Poria-Nelumbinis Semen 27∶30∶17∶12∶14) can improve the ovarian reserve function, and the former has better effect. Tusizi prescription can modulate biological processes (such as cell proliferation and apoptosis) and molecular functions (such as enzyme binding and estrogen response element binding) through active components like hyperoside to promote the proliferation and E
2
secretion and inhibit the apoptosis of KGN cells, thereby protecting the ovarian reserve function.
程萌 , 孔令伶俐 , 许良智 , 等 . 卵巢储备功能减退临床诊治专家共识解读 [J]. 实用妇产科杂志 , 2022 , 38 ( 10 ): 743 - 745 .
CHENG M , KONG L L L , XU L Z , et al . Interpretation of the expert consensus on the clinical diagnosis and treatment of ovarian reserve decline [J]. J Pract Obstet Gynecol , 2022 , 38 ( 10 ): 743 - 745 .
PASTORE L M , CHRISTIANSON M S , STELLING J , et al . Reproductive ovarian testing and the alphabet soup of diagnoses: DOR, POI, POF, POR, and FOR [J]. J Assist Reprod Genet , 2018 , 35 ( 1 ): 17 - 23 .
白园园 , 康志媛 . 针灸治疗卵巢储备功能减退机制研究进展 [J]. 辽宁中医药大学学报 , 2023 , 25 ( 5 ): 161 - 165 .
BAI Y Y , KANG Z Y . Research progress on mechanism of acupuncture and moxibustion in treating diminished ovarian reserve [J]. J Liaoning Univ Tradit Chin Med , 2023 , 25 ( 5 ): 161 - 165 .
JIAO Z , BUKULMEZ O . Potential roles of experimental reproductive technologies in infertile women with diminished ovarian reserve [J]. J Assist Reprod Genet , 2021 , 38 ( 10 ): 2507 - 2517 .
孙海旭 , 王枫 , 张普一 , 等 . 卵巢储备功能监测研究进展与卵巢早衰的预测 [J]. 国际生殖健康/计划生育杂志 , 2005 , 24 ( 5 ): 43 - 47 .
SUN H X , WANG F , ZHANG P Y , et al . Research progress on monitoring of ovarian reserve function and prediction of premature ovarian failure [J]. J Int Repr Heal/Fam Plan , 2005 , 24 ( 5 ): 43 - 47 .
杨一博 , 徐颖 , 王璐 , 等 . 基于Notch信号通路探索菟丝子总黄酮配伍雷公藤多苷对生理小鼠卵巢生殖干细胞的作用及机制 [J]. 中国实验方剂学杂志 , 2023 , 29 ( 5 ): 9 - 15 .
YANG Y B , XU Y , WANG L , et al . Effect and mechanism of Cuscutae Semen total flavon oids combined with Tripterygium wilfordii polyglycoside tablets on ovarian germline stem cells of physiological mice by Notch signaling pathway [J]. Chin J Exp Tradit Med Form , 2023 , 29 ( 5 ): 9 - 15 .
LI Y , DU H , LI J , et al . Exploring the protective effect of total flavonoids from Semen Cuscutae on ovarian germline stem cells based on notch signaling pathway [J]. Stem Cell Rev Rep , 2024 , 20 ( 3 ): 852 - 854 .
苗明三 , 马瑞娟 , 魏荣瑞 , 等 . 组分中药配比研究方法及思考 [J]. 河南大学学报:医学版 , 2011 , 30 ( 1 ): 1 - 5 .
MIAO M S , MA R J , WEI R R , et al . Method and thinking of component Chinese medicine ratio research [J]. J Henan Univ :Med Sci , 2011 , 30 ( 1 ): 1 - 5 .
杜寒倩 , 赵元 , 李泽辉 , 等 . 小鼠卵巢生殖干细胞分离培养鉴定 [J]. 基因组学与应用生物学 , 2023 , 42 ( 8 ): 845 - 855 .
DU H Q , ZHAO Y , LI Z H , et al . Isolation,culture and identification of ovarian germline stem cells in mus musculus [J]. Genom Appl Biol , 2023 , 42 ( 8 ): 845 - 855 .
杜寒倩 , 郭丽 , 赵元 , 等 . 基于Notch信号通路研究雷公藤多苷对体外培养小鼠卵巢生殖干细胞的毒性作用及机制研究 [J]. 中国中药杂志 , 2024 , 49 ( 6 ): 1594 - 1601 .
DU H Q , GUO L , ZHAO Y , et al . Toxic effect and mechanism of Tripterygium glycosides on ovarian germline stem cells of mice in vitro by Notch signaling pathway [J]. China J Chin Mater Med , 2024 , 49 ( 6 ): 1594 - 1601 .
陈碧霞 , 章勤 , 何嘉琳 . 何嘉琳治疗卵巢储备功能下降性不孕症经验 [J]. 浙江中西医结合杂志 , 2020 , 30 ( 12 ): 955 - 956,962 .
CHEN B X , ZHANG Q , HE J L . Dr. HE Jialin's experience in treating infertility due to decreased ovarian reserve function [J]. Zhejiang J Integr Tradit Chin West Med , 2020 , 30 ( 12 ): 955 - 956,962 .
刘亚娟 , 赵俐 . 卵巢储备功能下降的中医病因病机和治疗研究进展 [J]. 江西中医药 , 2022 , 53 ( 12 ): 74 - 77 .
LIU Y J , ZHAO L . Research progress on etiology pathogenesis and treatment of decreased ovarian reserve function in traditional Chinese medicine [J]. Jiangxi J Tradit Chin Med , 2022 , 53 ( 12 ): 74 - 77 .
吕孝丽 , 郜洁 , 周月希 , 等 . 罗颂平治疗卵巢储备功能下降不孕症经验 [J]. 中医杂志 , 2020 , 61 ( 13 ): 1139 - 1141 .
LU X L , GAO J , ZHOU Y X , et al . LUO Songping's experience in treating infertility due to decreased ovarian reserve function [J]. J Tradit Chin Med , 2020 , 61 ( 13 ): 1139 - 1141 .
王静 , 夏桂成 . 夏桂成从“心-肾-子宫轴”学说论治早发性卵巢功能不全经验 [J]. 中医杂志 , 2018 , 59 ( 7 ): 554 - 557,576 .
WANG J , XIA G C . XIA Guicheng's experience in treating premature ovarian insufficiency by "Heart-kidney-uterus Axis" theory [J]. J Tradit Chin Med , 2018 , 59 ( 7 ): 554 - 557,576 .
刘阳春 , 叶海峰 , 李小燕 , 等 . 卵巢生殖干细胞巢功能的影响因素和调控机制 [J]. 上海交通大学学报:医学版 , 2018 , 38 ( 6 ): 708 - 711 .
LIU Y C , YE H F , LI X Y , et al . Regulatory factors and modulation mechanisms of functions of ovarian germline stem cell niche [J]. J Shanghai Jiaotong Univ:Med Sci , 2018 , 38 ( 6 ): 708 - 711 .
SOLAK K A , WIJNOLTS F , NIJMEIJER S M , et al . Excessive levels of diverse phytoestrogens can modulate steroidogenesis and cell migration of KGN human granulosa-derived tumor cells [J]. Toxicol Rep , 2014 , 1 : 360 - 372 .
LIANG Y , SHI Y , GUO R , et al . Wine- and stir-frying processing of Cuscutae Semen enhance its ability to alleviate oxidative stress and apoptosis via the Keap1-Nrf2/HO-1 and PI3K/Akt pathways in H 2 O 2 -challenged KGN human granulosa cell line [J]. BMC Complement Med , 2024 , 24 ( 1 ): 189 .
史薇 , 刘敏 , 王智超 , 等 . 新加苁蓉菟丝子汤含药血清对雷公藤甲素诱导下人卵巢颗粒细胞线粒体能量代谢、氧化应激及动力学的影响 [J]. 中药材 , 2023 , 46 ( 10 ): 2573 - 2578 .
SHI W , LIU M , WANG Z C , et al . Effects of serum containing Xinjiacongrongtusisizi Soup on mitochondrial energy metabolism, oxidative stress and dynamics of human ovarian granulosa cells induced by tripterygium glycosides [J]. J Chin Med Mater , 2023 , 46 ( 10 ): 2573 - 2578 .
谢广妹 . 菟丝子水提取物对卵巢过度刺激大鼠细胞因子分泌的影响 [J]. 中药药理与临床 , 2010 , 26 ( 1 ): 45 - 47 .
XIE G M . The effect of Cuscuta chinensis L.on cytokines secretion in ovarian hyperstimulated rats [J]. Pharmacol Clin Chin Mater Med , 2010 , 26 ( 1 ): 45 - 47 .
JOZKOWIAK M , HUTCHINGS G , JANKOWSKI M , et al . The stemness of human ovarian granulosa cells and the role of resveratrol in the differentiation of MSCs-A review based on cellular and molecular knowledge [J]. Cells , 2020 , 9 ( 6 ): 1418 .
0
Views
206
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621